tiprankstipranks

David Lamond Insider Profile

4 Followers
David Lamond, Director at Quince Therapeutics, holds 6.69M shares in Quince Therapeutics (Ticker: QNCX), holds 1.08M shares in Applied Molecular Transport (Ticker: AMTI), holds ― shares in Lucira Health (Ticker: LHDXQ). Most recently, David Lamond Bought ― shares of Quince Therapeutics on Dec 14, 2023 for an estimated value of 69.23K.
tipranks
David Lamond

David Lamond
Quince Therapeutics (QNCX)
Director

Ranked #83,462 out of 99,635 Corporate Insiders

Profitable Transactions

36%
4 out of 11 Profitable Transactions

Average Return

-16.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$13M
100.00%
A breakdown of David Lamond's holdings

Insider Roles

Quince Therapeutics
(QNCX)
Director
Roles that David Lamond holds in companies

Most Profitable Insider Trade

Stock:
Quince Therapeutics
(QNCX)
Rating:Informative Buy
Date:Dec 01, 2023 - Today
Return:+104.10%
The most profitable trade made by David Lamond

David Lamond's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Quince Therapeutics
Dec 14, 2023
Director
Informative Buy
69.23K
$13.24M
AMTI
Applied Molecular Transport
May 23, 2022
Informative Buy
210.85K
$283.39K
LHDXQ
Lucira Health
List of latest transactions for each holding click on a transaction to see David Lamond's performance on stock

David Lamond insider profile FAQ

What is the percentage of profitable transactions made by David Lamond?
The percentage of profitable transactions made by David Lamond is 36%.
    What is the average return per transaction made by David Lamond?
    The average return per transaction made by David Lamond is -16.90%.
      What stocks does David Lamond hold?
      David Lamond holds: QNCX, AMTI, LHDXQ stocks.
        What was David Lamond’s latest transaction?
        David Lamond latest transaction was an Informative Buy of $69.23K.
          What was David Lamond's most profitable transaction?
          David Lamond’s most profitable transaction was an Informative Buy of QNCX stock on December 1, 2023. The return on the trade was 104.10%.
            What is David Lamond's role in Quince Therapeutics?
            David Lamond's role in Quince Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.